Predicting metastatic risk using past blood and tumor samples
Part of Cancer clinical trials.
This study looks at people diagnosed with PPGL (pheochromocytoma or paraganglioma) or certain gene changes that can lead to it. Researchers will use stored blood and tumor samples to build a tool that predicts the risk of spread (metastasis).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were diagnosed with PPGL (pheochromocytoma or paraganglioma) or have a gene variant that can cause it.
- Your diagnosis (or gene-related diagnosis) happened in Denmark, since 1996.
- Your samples are stored in Danish biobanks (either tumor tissue and/or blood).
- You must have at least one stored blood or tumor sample available for this research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people who have been newly diagnosed with pheochromocytoma/paraganglioma (PPGL), those with a past history of PPGL, or those with genetic risk for it. It may help doctors better evaluate and understand PPGL using specific tests.
This study looks at how the immune system responds to rare adrenal or nerve-related tumors (pheochromocytoma and paraganglioma). Researchers want to understand the tumor's environment, which may help improve future treatments.
This study looks at genetic (DNA) changes in people with pheochromocytoma or paraganglioma and related conditions. It may help clarify why these conditions happen and how they run in families.
This study helps doctors better understand and diagnose pheochromocytoma and paraganglioma—rare tumors that release stress hormones and cause high blood pressure and other symptoms. Researchers will study your medical history, blood and urine tests, imaging scans, and genetic information to improve how these conditions are found and understood.
This study aims to find genetic causes of neuroendocrine tumors in Mexican patients. By understanding your DNA, researchers hope to improve diagnosis and treatment for people with these rare conditions.
This study analyzes genetic information from blood samples in patients with advanced lung cancer, head and neck cancer, or mesothelioma who are starting chemotherapy and immunotherapy. Understanding your cancer's genetics may help doctors personalize treatment and improve outcomes.
Hear when a new Paraganglioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.